Jay Vora

Senior Vice President, Portfolio and Program Management @ Tenaya Therapeutics

Earned a Ph.D. in pharmacokinetics and clinical pharmacology from Northeastern University
Holds an M.S. in medicinal chemistry from the University of Cincinnati
Received an MBA from the Haas School of Business at the University of California, Berkeley
Previously served as head of alliance management and program leader on a gene therapy program at Sangamo
Was vice president of program and alliance management at REGENXBIO
Held roles in product development and program management at BioMarin and Chiron
Worked in management consulting at PRTM

Tenaya Therapeutics develops gene therapies and precision medicines for heart disease, founded by leading cardiovascular scientists.